Joseph Shulman

Directeur Technique/Scientifique/R&D chez RHYTHM PHARMACEUTICALS, INC.

Fortune : 1 145 $ au 30/04/2024

49 ans

Health Technology

Consumer Services

Postes actifs de Joseph Shulman

Sociétés	Poste	Début	Fin
RHYTHM PHARMACEUTICALS, INC.	Directeur Technique/Scientifique/R&D	27/07/2020	-

Sociétés	Poste	Début	Fin
RA PHARMACEUTICALS, INC.	Directeur Technique/Scientifique/R&D	01/07/2019	01/07/2020
NOVELION THERAPEUTICS INC.	Directeur Technique/Scientifique/R&D	01/09/2014	01/07/2019

Boston University	Masters Business Admin
University of Miami	Undergraduate Degree

Internationale

Etats-Unis	5
Canada	2

Opérationnelle

Sectorielle

Health Technology	4
Consumer Services	3

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
RHYTHM PHARMACEUTICALS, INC.	Health Technology

Entreprise privées	2
Ra Pharmaceuticals, Inc. Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA.	Health Technology
Novelion Therapeutics, Inc. Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada.	Health Technology

Entreprise privées

Health Technology